Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Chin

Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against China Medicine Corporation (OTCBB: CHME)

ID: 36505

(firmenpresse) - OKLAHOMA CITY, OK -- (Marketwire) -- 07/20/11 -- On July 15, 2011, a class action lawsuit was filed in the United States District Court for the Central District of California against China Medicine Corporation (OTCBB: CHME). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material misrepresentations to the market which had the effect of artificially inflating the market price. The class period is from November 30, 2006 through March 23, 2011.

Plaintiff seeks to recover damages on behalf of the Class. If you are a member of the Class as described above, you may move the Court no later than Friday, September 16, 2011, to serve as a lead plaintiff for the Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.

If you wish to discuss this action, participate in this or any other lawsuit, or have any questions or concerns regarding this notice, or preservation of your rights, please contact:



William B. Federman
FEDERMAN & SHERWOOD
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
(405) 235-1560
Email to:




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Jiangbo Pharmaceuticals, Inc. (NASDAQ: JGBO) The Law Firm of Levi & Korsinsky, LLP Notifies Shareholders of Claims of Breaches of Fiduciary Duty Against the Board of Immucor, Inc. in Connection With Takeover by TPG Capital
Bereitgestellt von Benutzer: MARKET WIRE
Datum: 20.07.2011 - 21:19 Uhr
Sprache: Deutsch
News-ID 36505
Anzahl Zeichen: 0

contact information:
Town:

OKLAHOMA CITY, OK



Kategorie:

Legal



Diese Pressemitteilung wurde bisher 223 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against China Medicine Corporation (OTCBB: CHME)"
steht unter der journalistisch-redaktionellen Verantwortung von

Federman & amp; Sherwood (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Federman & amp; Sherwood



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z